A critical function for type I interferons in cancer immunoediting
Top Cited Papers
- 12 June 2005
- journal article
- research article
- Published by Springer Nature in Nature Immunology
- Vol. 6 (7) , 722-729
- https://doi.org/10.1038/ni1213
Abstract
'Cancer immunoediting' is a process wherein the immune system protects hosts against tumor development and facilitates outgrowth of tumors with reduced immunogenicity. Although interferon-γ (IFN-γ) is known to be involved in this process, the involvement of type I interferons (IFN-α/β) has not been elucidated. We now show that, like IFN-γ, endogenously produced IFN-α/β was required for the prevention of the growth of primary carcinogen–induced and transplantable tumors. Although tumor cells are important IFN-γ targets, they are not functionally relevant sites of the actions of the type I interferons. Instead, host hematopoietic cells are critical IFN-α/β targets during development of protective antitumor responses. Therefore, type I interferons are important components of the cancer immunoediting process and function in a way that does not completely overlap the functions of IFN-γ.Keywords
This publication has 41 references indexed in Scilit:
- The Three Es of Cancer ImmunoeditingAnnual Review of Immunology, 2004
- Cross-priming of CD8+ T cells stimulated by virus-induced type I interferonNature Immunology, 2003
- Deficiencies of GM-CSF and Interferon γ Link Inflammation and CancerThe Journal of Experimental Medicine, 2003
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Inhibition of Methylcholanthrene-induced Carcinogenesis by an Interferon γ Receptor–dependent Foreign Body ReactionThe Journal of Experimental Medicine, 2002
- Antiviral response by natural killer cells throughTRAIL gene induction by IFN-α/βEuropean Journal of Immunology, 2001
- Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75.The Journal of Experimental Medicine, 1995
- Antibody to mouse interferon alpha/beta abrogates resistance to the multiplication of Friend erythroleukemia cells in the livers of allogeneic mice.The Journal of Experimental Medicine, 1988
- Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors.The Journal of Experimental Medicine, 1983
- Antitumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend leukemia cells. I.International Journal of Cancer, 1982